The Phage Therapy Market is increasingly associated with personalized medicine because phages can be selected or developed according to the bacterial strain responsible for an infection.

Phage banks and genomic sequencing technologies are helping researchers identify bacteriophages with activity against specific pathogens. Advances in sequencing and bioinformatics are also supporting the characterization and modification of phages for therapeutic applications.

Phage cocktails, which combine multiple bacteriophages, are another important area of development. Researchers are investigating these combinations as a way to broaden antibacterial coverage and potentially reduce the likelihood of bacterial resistance.